Sygnis Competitors and Similar CompaniesClear all
Sygnis's competitors and similar companies include Exogenesis, SynCell Biotechnology, Nvigen and Cellink.
 Exogenesis Exogenesis is a company that develops particle beam processing technologies to modify and control surfaces without applying a coating. |  SynCell Biotechnology SynCell Biotechnology is a company developing technologies to extract nanomaterials from bacteria. |  Nvigen Nvigen is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. |  Cellink CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products. | ||
Founding Date | Founding Date 2012 | Founding Date 2005 | Founding Date 2020 | Founding Date 2011 | Founding Date 2016 |
Type | Type Public | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Gdańsk, PL HQ Warszawa, PL Warszawa, PL | Locations Billerica, US HQ | Locations Boston, US HQ | Locations San Jose, US HQ San Jose, US | Locations Göteborg, SE HQ Dardilly, FR Kyoto, JP Göteborg, SE Brighton, GB Blacksburg, US Boston, US |
Employees | Employees 2924% decrease | Employees 147% decrease | Employees 4 | Employees 12 | Employees 851% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) zł9.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr74.2m (FY, 2021) |
Cost of goods | Cost of goods zł4.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods kr40.2m (FY, 2021) |
Gross profit | Gross profit zł6.7m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit kr34.1m (FY, 2021) |
Net income | Net income zł2.6m (FY, 2025) | Net income N/A | Net income N/A | Net income N/A | Net income (kr27.4m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 7.8m | Total funding raised N/A | Total funding raised $ 1.1m | Total funding raised $ 4.1m |
For sources of this data, please see the company profile
View Company Profiles
Exogenesis
HQ
Billerica, US
Employees
14↓ 7% decrease
Exogenesis is a company that develops particle beam processing technologies to modify and control surfaces without applying a coating.
View companySynCell Biotechnology
HQ
Boston, US
Employees
4
SynCell Biotechnology is a company developing technologies to extract nanomaterials from bacteria.
View companyNvigen
HQ
San Jose, US
Employees
12
Nvigen is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications.
View companyCellink
HQ
Göteborg, SE
CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
View company